BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21206387)

  • 1. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
    Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
    J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
    Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer.
    Ding X; Hui Z; Dai H; Fan C; Men Y; Ji W; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Lu N; He J; Wang L
    J Thorac Oncol; 2016 Sep; 11(9):1565-73. PubMed ID: 27223457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of the Currently Used Nodal Stage Classification with the Number of Metastatic Lymph Nodes and the Number of Metastatic Lymph Node Stations for Non-Small Cell Lung Cancer; Which of These Is the Best Prognostic Factor?
    Citak N; Aksoy Y; Isgörücü Ö; Obuz C; Acikmese B; Buyukkale S; Metin M; Sayar A
    Zentralbl Chir; 2020 Dec; 145(6):565-573. PubMed ID: 31648357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes.
    Liu H; Yan T; Zhang T; Chen X; Wang Y; Du J
    Medicine (Baltimore); 2019 May; 98(20):e15645. PubMed ID: 31096486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
    Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer.
    Lee JG; Lee CY; Bae MK; Park IK; Kim DJ; Kim KD; Chung KY
    J Thorac Oncol; 2008 Dec; 3(12):1421-6. PubMed ID: 19057267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems.
    Pepek JM; Chino JP; Marks LB; D'amico TA; Yoo DS; Onaitis MW; Ready NE; Hubbs JL; Boyd J; Kelsey CR
    J Thorac Oncol; 2011 Apr; 6(4):757-61. PubMed ID: 21325975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
    Maeshima AM; Tsuta K; Asamura H; Tsuda H
    Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact.
    Rena O; Boldorini R; Papalia E; Turello D; Massera F; Davoli F; Roncon A; Baietto G; Casadio C
    Ann Thorac Surg; 2014 Mar; 97(3):987-92. PubMed ID: 24480258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a thoracic surgeon identify lymph node metastases during surgery based on their size? Analysis of 844 metastatic and 10,462 nonmetastatic lymph nodes.
    Suemitsu R; Takeo S; Matsuzawa H; Yamaguchi M; Momosaki S; Uesugi N
    J Thorac Oncol; 2010 Mar; 5(3):349-53. PubMed ID: 20009772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which N Descriptor Is More Predictive of Prognosis in Resected Non-small Cell Lung Cancer: The Number of Involved Nodal Stations or the Location-Based Pathological N Stage?
    Xu L; Su H; She Y; Dai C; Zhao M; Gao J; Xie H; Ren Y; Xie D; Chen C
    Chest; 2021 Jun; 159(6):2458-2469. PubMed ID: 33352193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis.
    Yoshino I; Nakanishi R; Osaki T; Hasuda S; Taga S; Takenoyama M; Yoshimatsu T; Yasumoto K
    Ann Thorac Surg; 1997 Sep; 64(3):809-13. PubMed ID: 9307478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
    Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
    Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.